Diagnosing and Managing Steatotic Liver Disease
Metabolic dysfunction-associated steatotic liver disease is estimated to affect about 32.4% of the world’s population.
Read MorePosted by Chris Wolski | Nov 22, 2023 | Disease States |
Metabolic dysfunction-associated steatotic liver disease is estimated to affect about 32.4% of the world’s population.
Read MorePosted by Andy Lundin | Oct 20, 2023 | Diagnostic Technologies, Gastrointestinal Infections |
Laboratory services company PathAI Diagnostics unveiled an AI-assisted LDT for the histologic scoring and staging of MASLD and MASH.
Read MorePosted by Andy Lundin | Jul 14, 2022 | Diabetes & Metabolic Diseases |
This liquid biopsy test uses two circulating proteins to accurately test for non-alcoholic steato-hepatitis (NASH) and liver fibrosis.
Read MorePosted by Andy Lundin | Jul 5, 2022 | Diabetes & Metabolic Diseases |
In a study led by MedUni Vienna, a new method has now been used to determine alcohol consumption in fatty liver disease.
Read MorePosted by Andy Lundin | Jun 22, 2022 | Diabetes & Metabolic Diseases |
A specific subtype of macrophages in progressive NAFLD serve as useful biomarkers of liver disease progression.
Read More